Wednesday, April 20, 2011

Europe Pharmaceutical market share in Global pharmaceutical markets is decining as measure by share of europen countries in new drug launches

As Emerging markets are acquiring prominence and cost savings is becoming the core agenda among European health care regulators, these markets are increasingly becoming less important from the perspective of global pharmaceutical companies as targets for new drug launches.